Effects of 12 weeks’ treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study |
| |
摘 要: |
|
本文献已被 SpringerLink 等数据库收录! |
|